Biological Activity
Angiotensin-converting enzyme (ACE) inhibitor that is hydrolyzed in the liver to the active metabolite moexiprilat (IC50 values are 2.1 and 2700 nM for moexiprilat and moexipril respectively). Antihypertensive; decreases mean blood pressure in the spontaneous hypertensive rat (SHR). Also blocks degradation of bradykinin into inactive metabolites.
Technical Data
M. Wt | 535.03 |
Formula | C27H34N2O7.HCl |
Storage | Desiccate at +4°C |
Purity | ≥99% (HPLC) |
CAS Number | 82586-52-5 |
PubChem ID | 54889 |
InChI Key | JXRAXHBVZQZSIC-JKVLGAQCSA-N |
Smiles | O=C([C@@H](N[C@H]([C@@](OCC)=O)CCC3=CC=CC=C3)C)N2CC1=CC(OC)=C(OC)C=C1C[C@H]2[C@@](O)=O.Cl |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Solubility Data
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 53.5 | 100 | |
ethanol | 53.5 | 100 | |
water | 53.5 | 100 |
Preparing Stock Solutions
The following data is based on the product molecular weight 535.03. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.87 mL | 9.35 mL | 18.69 mL |
5 mM | 0.37 mL | 1.87 mL | 3.74 mL |
10 mM | 0.19 mL | 0.93 mL | 1.87 mL |
50 mM | 0.04 mL | 0.19 mL | 0.37 mL |
Molarity Calculator
Reconstitution Calculator
Dilution Calculator
Product Datasheets
References
References are publications that support the products' biological activity.
Edling et al (1995) Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. J.Pharmacol.Exp.Ther. 275 854 PMID: 7473177
Chrysant and Chrysant (2004) Pharmacological and clinical profile of moexipril: a concise review. J.Clin.Pharmacol. 44 827 PMID: 15286086
Friehe and Ney (1997) Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride. Arzneim.-Forsch. 47 132 PMID:
Keywords: Moexipril hydrochloride, supplier, Angiotensin-converting, enzyme, ACE, inhibitors, inhibits, Proteinases, Proteases, RS10085, RS, 10085, Angiotensin-Converting, Enzyme, Angiotensin-Converting, Enzyme, Tocris Bioscience